Needham & Company Upgrades Progenics Pharmaceuticals (PGNX) to Buy on Positive PSMA Data at ASCO-GU
Go back to Needham & Company Upgrades Progenics Pharmaceuticals (PGNX) to Buy on Positive PSMA Data at ASCO-GU| Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) | Delayed: 4.10 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.10 | 52 Week High | $7.75 | |||
| Open | $111.64 | 52 Week Low | $3.61 | |||
| Day High | $4.10 | P/E | N/A | |||
| Day Low | $4.10 | EPS | $-0.62 | |||
| Volume | 6,812 | |||||
